Corticosteroid-serotonin interactions in depression: A review of the human evidence

Psychopharmacology

Volumn 173, Issue 1, 2004, Pages 1-17

  Porter, Richard J ^a,b   Gallagher, Peter ^b   Watson, Stuart ^b   Young, Allan H ^b  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Corticosteroids; Depression; Drug interactions; Serotonin

Indexed keywords

5 HYDROXYTRYPTOPHAN; AMITRIPTYLINE; ANTIDEPRESSANT AGENT; BUSPIRONE; CITALOPRAM; CORTICOSTEROID; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; DEXFENFLURAMINE; FLESINOXAN; GLUCOCORTICOID RECEPTOR; GROWTH HORMONE; HYDROCORTISONE; IMIPRAMINE; IPSAPIRONE; MINERALOCORTICOID RECEPTOR; PROLACTIN; REBOXETINE; SEROTONIN; SEROTONIN 1 AGONIST; SEROTONIN 1A RECEPTOR; TRYPTOPHAN; VASOPRESSIN;

BINDING AFFINITY; DEPRESSION; DRUG ACTIVITY; DRUG EFFECT; DRUG RESPONSE; ELECTROENCEPHALOGRAM; HORMONE BLOOD LEVEL; HORMONE RELEASE; HUMAN; HYPERCORTISOLISM; HYPOTHALAMUS HYPOPHYSIS SYSTEM; MOOD DISORDER; NERVE ENDING; NEUROTRANSMISSION; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR BINDING; REVIEW; SEROTONINERGIC SYSTEM; STRESS; UPREGULATION;

ADRENAL CORTEX HORMONES; ANIMALS; DEPRESSION; EVIDENCE-BASED MEDICINE; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MEDLINE; PITUITARY-ADRENAL SYSTEM; SEROTONIN;

EID: 2342596369     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-004-1774-1     Document Type: Review

References (152)

1. American Psychiatric Association (1980) Diagnostic and statistical manual of mental disorders DSM-III, 3rd edn. American Psychiatric Association, Arlington, Va.
2. Amsterdam JD, Maislin G (1990) Comparison of growth hormone response after clonidine and insulin hypoglycemia in affective illness. Biol Psychiatry 28:308-314
3. Anderson IM, Ware CJ, da Roza Davis JM, Cowen PJ (1992) Decreased 5-HT-mediated prolactin release in major depression. Br J Psychiatry 160:372-378
4. Badawy AA, Morgan CJ, Lovett JW, Bradley DM, Thomas R (1995) Decrease in circulating tryptophan availability to the brain after acute ethanol consumption by normal volunteers: implications for alcohol-induced aggressive behaviour and depression. Pharmacopsychiatry 28:93-97
5. Barden N, Reul JM, Holsboer F (1995) Do antidepressants stabilize mood through actions on the hypothalamic-pituitary-adrenocortical system? Trends Neurosci 18:6-11
6. Barker WA, Scott J, Eccleston D (1987) The Newcastle chronic depression study: results of a treatment regime. Int Clin Psychopharmacol 2:261-272
7. Bhagwagar Z, Hafizi S, Cowen PJ (2002a) Cortisol modulation of 5-HT-mediated growth hormone release in recovered depressed patients. J Affect Disord 72:249-255
8. Bhagwagar Z, Whale R, Cowen PJ (2002b) State and trait abnormalities in serotonin function in major depression. Br J Psychiatry 180:24-28
9. Birmaher B, Dahl RE, Williamson DE, Perel JM, Brent DA, Axelson DA, Kaufman J, Dorn LD, Stull S, Rao U, Ryan ND (2000) Growth hormone secretion in children and adolescents at high risk for major depressive disorder. Arch Gen Psychiatry 57:867-872
10. Birmaher B, Dahl RE, Ryan ND, Williamson DE (2002) The role of hypothalamic-pituitary-adrenal axis dysfunction in the attenuated growth hormone response in adolescents with familial loading for affective disorder: in reply. Arch Gen Psychiatry 59:187
11. Blier P, Seletti B, Gilbert F, Young SN, Benkelfat C (2002) Serotonin 1A receptor activation and hypothermia in humans: Lack of evidence for a presynaptic mediation. Neuropsychopharmacology 27:301-308
12. Budziszewska B, Siwanowicz J, Przegaliski E (1995) Role of the serotoninergic system in the regulation of glucocorticoid and mineralocorticoid receptors in the rat hippocampus. Pol J Pharmacol 47:299-304
13. Burguera B, Muruais C, Penalva A, Dieguez C, Casanueva FF (1990) Dual and selective actions of glucocorticoids upon basal and stimulated growth hormone release in man. Neuroendocrinology 51:51-58
14. Casanueva FF, Burguera B, Tome MA, Lima L, Tresguerres JA, Devesa J, Dieguez C (1988) Depending on the time of administration, dexamethasone potentiates or blocks growth hormone-releasing hormone-induced growth hormone release in man. Neuroendocrinology 47:46-49
15. Caufriez A, Desir D, Szyper M, Robyn C, Copinschi G (1981) Prolactin secretion in Cushing's disease. J Clin Endocrinol Metab 53:843-846
16. Chaouloff F (1993) Physiopharmacological interactions between stress hormones and central serotonergic systems. Brain Res Brain Res Rev 18:1-32
17. Chaouloff F (2000) Serotonin, stress and corticoids. J Psychopharmacol 14:139-151
18. Charney DS, Heninger GR (1982) The effect of IV L-tryptophan on prolactin, growth hormone, and mood in healthy subjects. Psychopharmacology 78:38-43
19. Chernow B, Alexander HR, Smallridge RC, Thompson WR, Cook D, Beardsley D, Fink MP, Lake CR, Fletcher JR (1987) Hormonal responses to graded surgical stress. Arch Int Med 147:1273-1278
20. Cleare AJ, Murray RM, O'Keane V (1996) Reduced prolactin and cortisol responses to D-fenfluramine in depressed compared to healthy matched control subjects. Neuropsychopharmacology 14:349-354
21. 3 receptor antagonism by ondansetron does not attenuate prolactin response to D-fenfluramine challenge in healthy human subjects. Psychopharmacology 127:108-112
22. 2A/2C receptor blockade by amesergide fully attenuates prolactin response to D-fenfluramine challenge in physically healthy human subjects. Psychopharmacology 126:24-30
23. Coccaro EF, Kavoussi RJ, Cooper TB, Hauger R (1998) Acute tryptophan depletion attenuates the prolactin response to D-fenfluramine challenge in healthy human subjects. Psychopharmacology 138:9-15
24. Cowen PJ (1996) The serotonin hypothesis: necessary but not sufficient In: Feighner J, Boyer W (eds) Selective serotonin reuptake inhibitors. Wiley, Chichester, pp 63-86
25. Cowen PJ, Charig EM (1987) Neuroendocrine responses to intravenous tryptophan in major depression. Arch Gen Psychiatry 44:958-66
26. Da Roza Davis JM, Cowen PJ (2001) Biochemical stress of caring. Psychol Med 31:1475-1478
27. Dannies PS, Tashjian AR Jr (1973) Effects of thyrotropin-releasing hormone and hydrocortisone on synthesis and degradation of prolactin in a rat pituitary cell strain. J Biol Chem 248:6174-9
28. 1 receptor capacity in raphé-hippocampal system. Neuroendocrinology 42:513-521
29. Deakin JF, Pennell I, Upadhyaya AJ, Lofthouse R (1990) A neuroendocrine study of 5HT function in depression: evidence for biological mechanisms of endogenous and psychosocial causation. Psychopharmacology 101:85-92
30. Deuschle M, Schweiger U, Weber B, Gotthardt U, Korner A, Schmider J, Standhardt H, Lammers CH, Heuser I (1997) Diurnal activity and pulsatility of the hypothalamus-pituitary-adrenal system in male depressed patients and healthy controls. J Clin Endocrinol Metab 82:234-238
31. Dinan TG (1994) Glucocorticoids and the genesis of depressive illness. A psychobiological model Br J Psychiatry 164:365-371
32. Dinan TG, Scott LV (1996) The influence of cortisol on spontaneous and 5HT stimulated prolactin release in man. J Basic Clin Physiol Pharmacol 7:45-56
33. Dinan TG, Thakore J, V OK (1994) Lowering cortisol enhances growth hormone response to growth hormone releasing hormone in healthy subjects. Acta Physiol Scand 151:413-416
34. Dinan TG, Scott LV, Thakore J, Naesdal J, Keeling PW (2001) Impact of cortisol on buspirone stimulated prolactin release: a double-blind placebo-controlled study. Psychoneuroendocrinology 26:751-756
35. Dolan RJ, Calloway SP (1986) The human growth hormone response to clonidine: relationship to clinical and neuroendocrine profile in depression. Am J Psychiatry 143:772-774
36. Drevets WC, Frank E, Price JC, Kupfer DJ, Holt D, Greer PJ, Huang Y, Gautier C, Mathis C (1999) PET imaging of serotonin 1A receptor binding in depression. Biol Psychiatry 46:1375-1387
37. Duman RS, Heninger GR, Nestler EJ (1997) A molecular and cellular theory of depression. Arch Gen Psychiatry 54:597-606
38. Duval F, Mokrani MC, Correa H, Bailey P, Valdebenito M, Monreal J, Crocq MA, Macher JP (2001) Lack of effect of HPA axis hyperactivity on hormonal responses to D-fenfluramine in major depressed patients: implications for pathogenesis of suicidal behaviour. Psychoneuroendocrinology 26:521-537
39. 1A autoreceptor function in humans. J Psychopharmacol 17:A76
40. Frantz AG, Rabkin JG (1964) Clinical Measurement, response to hypoglycaemia and suppression by corticosteroids. N Engl J Med 271:1375-1381
41. Fuller RW (1992) The involvement of serotonin in regulation of pituitary-adrenocortical function. Front Neuroendocrinol 13:250-270
42. Fuxe K, Butcher LL, Engel J (1971) DL-5-Hydroxytryptophan-induced changes in central monoamine neurons after peripheral decarboxylase inhibition. J Pharm Pharmacol 23:420-424
43. Giustina A, Romanelli G, Candrina R, Giustina G (1989) Growth hormone deficiency in patients with idiopathic adrenocorticotropin deficiency resolves during glucocorticoid replacement. J Clin Endocrinol Metab 68:120-124
44. Giustina A, Doga M, Bodini C, Girelli A, Legati F, Bossoni S, Romanelli G (1990) Acute effects of cortisone acetate on growth hormone response to growth hormone-releasing hormone in normal adult subjects. Acta Endocrinol 122:206-210
45. Gold PW, Loriaux DL, Roy A, Kling MA, Calabrese JR, Kellner CH, Nieman LK, Post RM, Pickar D, Gallucci W (1986) Responses to corticotropin-releasing hormone in the hypercortisolism of depression and Cushing's disease. Pathophysiologic and diagnostic implications. N Engl J Med 314:1329-1335
46. Golden RN, Ruegg R, Brown TM, Haggerty J, Jr., Garbutt JC, Pedersen CA, Evans DL (1990) Abnormal neuroendocrine responsivity to clomipramine in depression. Psychopharmacol Bull 26:317-320
47. Goodall EM, Cowen PJ, Franklin M, Silverstone T (1993) Ritanserin attenuates anorectic, endocrine and thermic responses to D-fenfluramine in human volunteers. Psychopharmacology 112:461-466
48. Greden JF, Gardner R, King D, Grunhaus L, Carroll BJ, Kronfol Z (1983) Dexamethasone suppression tests in antidepressant treatment of melancholia. The process of normalization and test-retest reproducibility. Arch Gen Psychiatry 40:493-500
49. Gregory CA, Anderson IM, Cowen PJ (1990) Metergoline abolishes the prolactin response to buspirone. Psychopharmacology 100:283-284
50. Guazzo EP, Kirkpatrick PJ, Goodyer IM, Shiers HM, Herbert J (1996) Cortisol, dehydroepiandrosterone (DHEA), and DHEA sulfate in the cerebrospinal fluid of man: relation to blood levels and the effects of age. J Clin Endocrinol Metab 81:3951-3960
51. Harmer CJ, Bhagwagar Z, Shelley N, Cowen PJ (2003) Contrasting effects of citalopram and reboxetine on waking salivary cortisoL Psychopharmacology 167:112-114
52. Heninger GR, Charney DS, Price L, Delgado P, Woods S, Goodman W (1990) Neuroendocrine effects of serotonin agonists in rhesus monkeys, healthy humans and patients with depression or anxiety disorders: effects of anti-depressant treatment In: Paoletti R, Vanhoutte PM, Brunello N, Maggi FM (eds) Serotonin: cell biology to pharmacology and therapeutics. Kluwer Acadmic, Dordrecht, pp 559-563
53. Hesselmann B, Neumeister A, Praschak-Rieder N, Vitouch O, Kasper S (1997) Cortisol concentration during tryptophan depletion in depressed and remitted patients with seasonal affective disorder (SAD) 6th World Congress of Biological Psychiatry, Nice, pp 39-123
54. Heuser I, Yassouridis A, Holsboer F (1994) The combined dexamethasone/CRH test: a refined laboratory test for psychiatric disorders. J Psychiatr Res 28:341-356
55. Heuser IJ, Schweiger U, Gotthardt U, Schmider J, Lammers CH, Dettling M, Yassouridis A, Holsboer F (1996) Pituitary-adrenaL-system regulation and psychopathology during amitriptyline treatment in elderly depressed patients and normal comparison subjects. Am J Psychiatry 153:93-99
56. Hirota T, Hirota K, Sanno Y, Tanaka T (1985) A new glucocorticoid receptor species: relation to induction of tryptophan dioxygenase by glucocorticoids. Endocrinology 117:1788-1795
57. Holsboer F, Barden N (1996) Antidepressants and hypothalamic-pituitary- adrenocortical regulation. Endocrine Rev 17:187-205
58. Holsboer F, Von Bardeleben U, Gerken A, Stalla GK, Muller OA (1984) Blunted corticotropin and normal cortisol response to human corticotropin- releasing factor in depression. N Engl J Med 311:1127
59. Holsboer F, Lauer CJ, Schreiber W, Krieg JC (1995) Altered hypothalamic-pituitary-adrenocortical regulation in healthy subjects at high familial risk for affective disorders. Neuroendocrinology 62:340-347
60. Holsboer-Trachsler E, Stohler R, Hatzinger M (1991) Repeated administration of the combined dexamethasone-human corticotropin releasing hormone stimulation test during treatment of depression. Psychiatry Res 38:163-171
61. Inder WJ, Prickett TC, Mulder RT, Donald RA, Joyce PR (2001) Reduction in basal afternoon plasma ACTH during early treatment of depression with fluoxetine. Psychopharmacology 156:73-78
62. Invernizzi R, Berettera C, Garattini S, Samanin R (1986) D- and L-isomers of fenfluramine differ markedly in their interaction with brain serotonin and catecholamines in the rat. Eur J Pharmacol 120:9-15
63. Joseph MH, Kennett GA (1983) Corticosteroid response to stress depends upon increased tryptophan availability. Psychopharmacology 79:79-81
64. Kahn RS, Wetzler S, Asnis GM, Papolos D, Van Praag HM (1990) Serotonin receptor sensitivity in major depression. Biol Psychiatry 28:358-362
65. Kasuya Y, Iwano M, Shibasaki H, Furuta T (1995) Pharmacokinetic studies of cortisol after oral administration of deuterium-labelled cortisol to a normal human subject Rapid Commun Mass Spectrom Spec No: S29-34
66. Kathol RG, Jaeckle R, Wysham C, Sherman B (1991) Imipramine effect on the hypothalamic-pituitary-adrenal axis response to hypoglycemia. Psychiatry Res 41:2-52
67. Koyama T, Meltzer H (1986) A biochemical and neuroendocrine study of the serotonergic system in depression. In: Hippius H et al. (eds) New results in depression research. Springer, Berlin, Heidelberg, New York, pp 169-188
68. 2 receptor binding and 5-HT transporter mRNA expression in rat brain. Brain Res 648:157-61
69. Laakmann G (1990) Psychopharmacoendocrinology and depression research. Springer-Verlag, Berlin, Heidelberg, New York
70. 1A autoreceptor function in the rat: relevance for depression. Neuropsychopharmacology 28:119-125
71. Lesch KP, Muller U, Rupprecht R, Kruse K, Schulte HM (1989a) Endocrine responses to growth hormone-releasing hormone, thyrotropin-releasing hormone and corticotropin-releasing hormone in depression. Acta Psychiatr Scand 79:597-602
72. Lesch KP, Rupprecht R, Poten B, Muller U, Sohnle K, Fritze J, Schulte HM (1989b) Endocrine responses to 5-hydroxytryptamine-1A receptor activation by ipsapirone in humans. Biol Psychiatry 26:203-205
73. Lesch KP, Disselkamp-Tietze J, Schmidtke A (1990) 5-HT1A receptor function in depression: effect of chronic amitriptyline treatment. J Neural Transm [Gen Sect] 80:157-161
74. Maes M, Meltzer HY (1995) The serotonin hypothesis of major depression. In: Bloom FE, Kupfer DJ (eds) Psychopharmacology: the fourth generation of progress. Raven Press, New York, pp 933-944
75. Maes M, De Ruyter M, Claes R, Bosma G, Suy E (1987a) The cortisol responses to 5-hydroxytryptophan, orally, in depressive inpatients. J Affect Disord 13:23-30
76. Maes M, De Ruyter M, Hobin P, Suy E (1987b) Relationship between the dexamethasone suppression test and the L-tryptophan/competing amino acids ratio in depression. Psychiatry Res 21:323-335
77. Maes M, De Ruyter M, Claes R, Suy E (1988) Sex-related differences in the relationships between self-rated depression and biological markers. J Affect Disord 15:119-25
78. Maes M, Jacobs MP, Suy E, Minner B, Leclercq C, Christiaens F, Raus J (1990a) Suppressant effects of dexamethasone on the availability of plasma L-tryptophan and tyrosine in healthy controls and in depressed patients. Acta Psychiatr Scand 81:19-23
79. Maes M, Schotte C, Scharpe S, Martin M, Blockx P (1990b) The effects of glucocorticoids on the availability of L-tryptophan and tyrosine in the plasma of depressed patients. J Affect Disord 18:121-127
80. Maes M, Vandewoude M, Schotte C, Maes L, Martin M, Scharpe S, Blockx P (1990c) The relationships between the cortisol responses to dexamethasone and to L-5-HTP, and the availability of L-tryptophan in depressed females. Biol Psychiatry 27:601-608
81. Maes M, D'Hondt P, Martin M, Claes M, Schotte C, Vandewoude M, Blockx P (1991a) L-5-Hydroxytryptophan stimulated cortisol escape from dexamethasone suppression in melancholic patients. Acta Psychiatr Scand 83:302-306
82. Maes M, D'Hondt P, Suy E, Minner B, Vandervorst C, Raus J (1991b) HPA-axis hormones and prolactin responses to dextrofenfluramine in depressed patients and healthy controls. Prog Neuropsychopharmacol Biol Psychiatry 15:781-790
83. Maes M, Meltzer HY, P DH, Cosyns P, Blockx P (1995) Effects of serotonin precursors on the negative feedback effects of glucocorticoids on hypothalamic-pituitary-adrenal axis function in depression. Psychoneuroendocrinology 20:149-167
84. Mahmood I, Sahajwalla C (1999) Clinical pharmacokinetics and pharmacodynamics of buspirone, an anxiolytic drug. Clin Pharmacokinet 36:277-287
85. Martire M, Pistritto G, Preziosi P (1989) Different regulation of serotonin receptors following adrenal hormone imbalance in the rat hippocampus and hypothalamus. J Neural Transm 78:109-120
86. Matussek N, Ackenheil M, Hippius H, Muller F, Schroder HT, Schultes H, Wasilewski B (1980) Effect of clonidine on growth hormone release in psychiatric patients and controls. Psychiatry Res 2:25-36
87. 1A receptor function in humans. Psychopharmacology 166:284-293
88. McAllister-Williams RH, Ferrier IN, Young AH (1998) Mood and neuropsychological function in depression: the role of corticosteroids and serotonin. Psychol Med 28:573-584
89. McCance SL, Cowen PJ, Waller H, Grahame-Smith DG (1987) The effects of metergoline on endocrine responses to L-tryptophan. J Psychopharmacol 2:90-94
90. McTavish SFB, McPherson MH, Harmer CJ, Clark L, Sharp T, Goodwin GM, Cowen PJ (2001) Antidopaminergic effects of dietary tyrosine depletion in healthy subjects and patients with manic illness. Br J Psychiatry 179:356-360
91. 1A receptor mRNA in rat dentate gyms. Eur J Pharmacol 266:255-261
92. Meijer OC, de Lange EC, Breimer DD, de Boer AG, Workel JO, de Kloet ER (1998) Penetration of dexamethasone into brain glucocorticoid targets is enhanced in mdr1A P-glycoprotein knockout mice. Endocrinology 139:1789-1793
93. Meltzer HY, Maes M (1994) Effect of pindolol on the L-5-HTP-induced increase in plasma prolactin and cortisol concentrations in man. Psychopharmacology 114:635-643
94. Meltzer HY, Maes M (1995) Effects of ipsapirone on plasma cortisol and body temperature in major depression. Biol Psychiatry 38:450-457
95. Meltzer HY, Umberkoman-Wiita B, Robertson A, Tricou BJ, Lowy M, Perline R (1984) Effect of 5-hydroxytryptophan on serum cortisol levels in major affective disorders. I. Enhanced response in depression and mania. Arch Gen Psychiatry 41:366-374
96. 1A receptor stimulation. Arch Gen Psychiatry 49:163-164
97. 1B receptors in the dorsal hippocampus and cortex of the rat. Neuroendocrinology 55:444-450
98. 1A receptors in rat forebrain. Neuroendocrinology 56:881-888
99. Michelson D, Galliven E, Hill L, Demitrack M, Chrousos G, Gold P (1997) Chronic imipramine is associated with diminished hypothalamic-pituitary-adrenal axis responsivity in healthy humans. J Clin Endocrinol Metab 82:2601-2606
100. 2-induced anxiety in patients with panic disorder and normal volunteers. Br J Psychiatry 176:182-188
101. Mitchell P, Smythe G (1990) Hormonal responses to fenfluramine in depressed and control subjects. J Affect Disord 19:43-51
102. Mokrani MC, Duval F, Crocq MA, Bailey P, Macher JP (1997) HPA axis dysfunction in depression: correlation with monoamine system abnormalities. Psychoneuroendocrinology 22: S63-S68
103. Montgomery AJ, Bench CJ, Young AH, Hammers A, Gunn RN, Bhagwagar Z, Grasby PM (2001) PET measurement of the influence of corticosteroids on serotonin-1A receptor number. Biol Psychiatry 50:668-676
104. Mulder RT, Porter RJ, Joyce PR (2003) The prolactin response to fenfluramine in depression - the effects of melancholia and baseline cortisol. J Psychopharmacol 17:97-102
105. Nemeroff CB (1996) The corticotropin-releasing factor (CRF) hypothesis of depression: new findings and new directions. Mol Psychiatry 1:336-342
106. Newcomer JW, Selke G, Melson AK, Hershey T, Craft S, Richards K, Alderson AL (1999) Decreased memory performance in healthy humans induced by stress level cortisol treatment. Arch Gen Psychiatry 56:527-533
107. Newman M, Shapira B, Lerer B (1998) Evaluation of central serotonergic function in affective and related disorders by the fenfluramine challenge test : a critical review. Int J Neuropsychopharmacol 1:49-69
108. Nuller JL, Ostroumova MN (1980) Resistance to inhibiting effect of dexamethasone in patients with endogenous depression. Acta Psychiatr Scand 61:169-177
109. Park SB, Williamson DJ, Cowen PJ (1996) 5-HT neuroendocrine function in major depression: prolactin and cortisol responses to D-fenfluramine. Psychol Med 26:1191-1196
110. Peroutka SJ (1988) 5-Hydroxytryptamine receptor subtypes. Annu Rev Neurosci 11:45-60
111. 1A receptor activity. Neuropsychobiology 44:74-77
112. Porter RJ, McAllister-Williams RH, Lunn BS, Young AH (1998) 5-Hydroxytryptamine receptor function in man is reduced by acute administration of hydrocortisone. Psychopharmacology 139:243-250
113. Porter RJ, McAllister-Williams RH, Jones S, Young AH (1999) Effects of dexamethasone on neuroendocrine and psychological responses to L-tryptophan infusion. Psychopharmacology 143:64-71
114. Porter RJ, Gallagher P, Watson S, Lunn B, Young AH (2002a) The effects of sub-chronic administration of hydrocortisone on hormonal and psychological responses to L-tryptophan in normal male volunteers. Psychopharmacology 163:68-75
115. Porter RJ, Marshall EF, O"Brien JT (2002b) Effects of rapid tryptophan depletion on salivary and plasma cortisol in Alzheimer"s disease and the healthy elderly. J Psychopharmacol 16:73-78
116. Porter RJ, Gallagher P, Watson S, Smith MS, Young AH (2003) Elevated prolactin responses to L-tryptophan infusion in medication-free depressed patients. Psychopharmacology 169: 77-83
117. Power AC, Cowen PJ (1992) Neuroendocrine challenge tests: assessment of 5-HT function in anxiety and depression. Mol Aspects Med 13:205-20
118. Price LH, Charney DS, Delgado PL, Heninger GR (1991) Serotonin function and depression: neuroendocrine and mood responses to intravenous L-tryptophan in depressed patients and healthy comparison subjects. Am J Psychiatry 148:1518-1525
119. 1A function in depressed patients and healthy subjects. Neuropsychopharmacology 17:246-257
120. Price LH, Malison RT, McDougle CJ, McCance-Katz EF, Owen KR, Heninger GR (1997b) Neurobiology of tryptophan depletion in depression: effects of m-chlorophenylpiperazine (mCPP). Neuropsychopharmacology 17:342-350
121. Price LH, Malison RT, McDougle CJ, Pelton GH, Heninger GR (1998a) The neurobiology of tryptophan depletion in depression: effects of intravenous tryptophan infusion. Biol Psychiatry 43:339-347
122. Price ML, Curtis AL, Kirby LG, Valentino RJ, Lucki I (1998b) Effects of corticotropin-releasing factor on brain serotonergic activity. Neuropsychopharmacology 18:492-502
123. Rajewska J, Rybakowski JK (2003) Depression in premenopausal women: gonadal hormones and serotonergic system assessed by D-fenfluramine challenge test. Prog Neuropsychopharmacol Biol Psychiatry 27:705-709
124. Rang HP, Dale MM (1991) Pharmacology, 2nd edn. Churchill Livingstone, Edinburgh, New York
125. Reul JM, de Kloet ER, van Sluijs FJ, Rijnberk A, Rothuizen J (1990) Binding characteristics of mineralocorticoid and glucocorticoid receptors in dog brain and pituitary. Endocrinology 127:907-915
126. Riedel W, Klaassen T, Griez E, Honig A, Menheere P, Van Praag HM (2002a) Dissociable hormonal, cognitive and mood responses to neuroendocrine challenge: evidence for receptor-specific serotonergic dysregulation in depressed mood. Neuropsychopharmacology 26:358-367
127. Riedel WJ, Sobczak S, Nicolson N, Honig A (2002b) Stress, cortisol and memory as markers of serotonergic vulnerability. Acta Neuropsychiatrica 14:186-191
128. Rubin R, Poland R, Lesser I, Winston R, Blodgett N (1987) Neuroendocrine aspects of primary endogenous depression, cortisol secretory dynamics in patients and matched controls. Arch Gen Psychiatry 44:328-336
129. Sachar EJ, Hellman L, Roffwarg HP, Halpern FS, Fukushima DK, Gallagher TF (1973) Disrupted 24-hour patterns of cortisol secretion in psychotic depression. Arch Gen Psychiatry 28:19-24
130. 11C]WAY-100635: effects of depression and antidepressant treatment Arch Gen Psychiatry 57:174-180
131. Shapira B, Newman ME, Gelfin Y, Lerer B (2000) Blunted temperature and cortisol responses to ipsapirone in major depression: lack of enhancement by electroconvulsive therapy. Psychoneuroendocrinology 25:421-438
132. Skare SS, Dysken MW, Billington CJ (1994) A review of GHRH stimulation test in psychiatry. Biol Psychiatry 36:249-265
133. Smith CE, Ware CJ, Cowen PJ (1991) Pindolol decreases prolactin and growth hormone responses to intravenous L-tryptophan. Psychopharmacology 103:140-142
134. Smith KA, Williams C, Cowen PJ (2000) Impaired regulation of brain serotonin function during dieting in women recovered from depression. Br J Psychiatry 176:72-75
135. Smythe GA, Mitchell PB (1992) Endocrine and amine responses to D,L-fenfluramine in normal subjects. Am J Psychiatry 149:851-2
136. Sobczak S, Honig A, Nicholson N, Riedel W (2002) Effects of acute tryptophan depletion on mood and cortisol release in first-degree relatives of type I and type II bipolar patients and healthy matched controls. Neuropsychopharmacology 27:834-842
137. Sowers JR, Hershman JM, Showsky WR, Carlson HE, Park J (1977) Osmotic control of the release of prolactin and thyrotropin in euthyroid subjects and patients with pituitary tumors. Metabolism 26:187-192
138. Steckler T, Holsboer F, Reul JMH (1999) Glucocorticoids and depression. Bailliere's Best Pract Res Clin Endocrinol Metab 13:597-614
139. Steiger A, Holsboer F (1997) Neuropeptides and human sleep. Sleep 20:1038-1052
140. Strickland PL, Deakin JF, Percival C, Dixon J, Gater RA, Goldberg DP (2002) Bio-social origins of depression in the community. Interactions between social adversity, cortisol and serotonin neurotransmission. Br J Psychiatry 180:168-173
141. Thakore JH, Dinan TG (1994) Growth hormone secretion: the role of glucocorticoids. Life Sci 55:1083-1099
142. Traskman-Bendz L, Haskett RF, Zis AP (1986) Neuroendocrine effects of L-tryptophan and dexamethasone. Psychopharmacology 89:85-88
143. van Praag HM, Lemus C, Kahn R (1987) Hormonal probes of central serotonergic activity: do they really exist? Biol Psychiatry 22:86-98
144. Vining RF, McGinley RA, Maksvytis JJ, Ho KY (1983) Salivary cortisol: a better measure of adrenal cortical function than serum cortisol. Ann Clin Biochem 20:329-335
145. Wajchenberg BL, Liberman B, Neto DG, Morozimato MY, Semer M, Bracco LO, Salgado LR, Knoepfelmacher M, Borges MHS, Pinto ACAR, Kater CE, Lengyel AMJ (1996) Growth hormone axis in Cushing's syndrome. Horm Res 45:99-107
146. Watson S, Porter RJ, Young AH (2000) Effect of hydrocortisone on the pituitary response to growth hormone releasing hormone. Psychopharmacology 152:40-46
147. Hearn AJ, Gallagher P, Owen BM, Smith MS, Watson S, Young AH (2004) Effect of sub-chronic hydrocortisone on responses to amphetamine in normal male volunteers. Psychopharmacology 171:458-464
148. Wurtman RJ (1982) Nutrients that modify brain function. Sci Am 246:50-59
149. Young AH, Sharpley AL, Campling GM, Hockney RA, Cowen PJ (1994) Effects of hydrocortisone on brain 5-HT function and sleep. J Affect Disord 32:139-146
150. Young AH, Rue J, Odontiadis J, Cowen PJ (1998) Lack of effect of hydrocortisone treatment on D-fenfluramine-mediated prolactin release. Psychopharmacology 136:198-200
151. Young EA, Lopez JF, Murphy-Weinberg V, Watson SJ, Akil H (2003) Mineralocorticoid receptor function in major depression. Arch Gen Psychiatry 60:24-28
152. Zobel AW, Nickel T, Sonntag A, Uhr M, Holsboer F, Ising M (2001) Cortisol response in the combined dexamethasone/CRH test as predictor of relapse in patients with remitted depression: a prospective study. J Psychiatr Res 35:83-94